Fidelity Advisor Diversified International Fund (FADCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
23.56
+0.05 (0.21%)
Dec 26, 2024, 8:01 PM EST
1.64% (1Y)
Fund Assets | 1.41B |
Expense Ratio | 1.87% |
Min. Investment | $0.00 |
Turnover | 23.00% |
Dividend (ttm) | 1.34 |
Dividend Yield | 5.69% |
Dividend Growth | 67.67% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 13, 2024 |
Previous Close | 23.51 |
YTD Return | 0.86% |
1-Year Return | 1.64% |
5-Year Return | 17.48% |
52-Week Low | 22.71 |
52-Week High | 27.00 |
Beta (5Y) | 1.06 |
Holdings | 135 |
Inception Date | Dec 17, 1998 |
About FADCX
The fund primarily invests in non-U.S. securities. It invests primarily in common stocks. The advisor allocates investments across different countries and regions. The advisor uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Fund Family Fidelity
Category Intl Large-Cap Growth
Performance Rating Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol FADCX
Index MSCI EAFE NR USD
Performance
FADCX had a total return of 1.64% in the past year. Since the fund's inception, the average annual return has been 5.57%, including dividends.
Top 10 Holdings
22.50% of assetsName | Symbol | Weight |
---|---|---|
Hitachi, Ltd. | 6501 | 2.85% |
Fidelity Revere Street Trust - Fidelity Cash Central Fund | n/a | 2.77% |
ASML Holding N.V. | ASML | 2.75% |
Novo Nordisk A/S | NOVO.B | 2.48% |
Taiwan Semiconductor Manufacturing Company Limited | TSM | 2.47% |
SAP SE | SAP | 2.38% |
AstraZeneca PLC | AZN | 1.85% |
RELX PLC | REL | 1.78% |
Wolters Kluwer N.V. | WKL | 1.60% |
London Stock Exchange Group plc | LSEG | 1.58% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 13, 2024 | $1.338 | Dec 16, 2024 |
Dec 8, 2023 | $0.798 | Dec 11, 2023 |
Dec 9, 2022 | $0.400 | Dec 12, 2022 |
Dec 3, 2021 | $2.847 | Dec 6, 2021 |
Dec 6, 2019 | $0.080 | Dec 9, 2019 |
Dec 7, 2018 | $0.735 | Dec 10, 2018 |